Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Partners Lp Caligan currently holds 8,138,951 shares of STANDARD BIOTOOLS INC. (LAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners Lp Caligan has been a net buyer of LAB stock. They have purchased $32.3M and sold $4.3M worth of shares.
Partners Lp Caligan's most recent insider trade was on May 19, 2026, when they purchased 5,300 shares at $59.98 per share.
Partners Lp Caligan serves as Executive at STANDARD BIOTOOLS INC. (LAB). They have executed 32 insider transactions totaling $36.6M over their tenure at the company.
Partners Lp Caligan holds the position of Executive at STANDARD BIOTOOLS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Partners Lp Caligan has shown a buying trading pattern, with $32.3M in total purchases and $4.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Partners Lp Caligan was on Sep 12, 2024, when they purchased $10.0M worth of LQDA shares. This transaction involved 1,123,595 shares at $8.90 per share.
Partners Lp Caligan currently owns 8,138,951 shares of STANDARD BIOTOOLS INC. (LAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Partners Lp Caligan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Partners Lp Caligan has 32 Form 4 filings on record as an insider at STANDARD BIOTOOLS INC..
Set alerts for Partners Lp Caligan and 40,000+ other insiders.